Free Trial

Corbus Pharmaceuticals (CRBP) Insider Trading & Ownership

Corbus Pharmaceuticals logo
$11.04 +0.08 (+0.73%)
Closing price 05/11/2026 04:00 PM Eastern
Extended Trading
$11.76 +0.72 (+6.52%)
As of 05:39 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Corbus Pharmaceuticals (NASDAQ:CRBP) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.50%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$1.13M
Get CRBP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Corbus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CRBP Insider Buying and Selling by Quarter

Corbus Pharmaceuticals Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/3/2026
Dominic Smethurst
Insider
Sell3,285$8.09$26,575.65  
2/3/2026
Ian Hodgson
COO
Sell2,415$8.09$19,537.35  
12/11/2025
Cormorant Asset Management, Lp
Major Shareholder
Sell30,029$11.46$344,132.34  
10/27/2025Sell8,973$17.14$153,797.22  
10/24/2025
Sean F Moran
CFO
Sell12,981$17.02$220,936.62  
10/24/2025Sell18,660$17.01$317,406.60  
10/20/2025
Anne Altmeyer
Director
Sell1,060$20.50$21,730.00  
5/30/2025
Anne Altmeyer
Director
Sell1,392$7.25$10,092.00  
5/30/2025
John Kenneth Jenkins
Director
Sell2,783$7.35$20,455.05  
(Data available from 1/1/2013 forward)

CRBP Insider Trading Activity - Frequently Asked Questions

The list of insiders at Corbus Pharmaceuticals includes Anne Altmeyer, Cormorant Asset Management, Lp, Dominic Smethurst, Ian Hodgson, John Kenneth Jenkins, Sean F Moran, and Yuval Cohen. Learn more on insiders at CRBP.

3.50% of Corbus Pharmaceuticals stock is owned by insiders. Learn more on CRBP's insider holdings.

The following insider purchased CRBP shares in the last 24 months: Cormorant Asset Management, Lp ($7,003,500.00).

Insiders have purchased a total of 350,000 CRBP shares in the last 24 months for a total of $7,003,500.00 bought.

The following insiders have sold CRBP shares in the last 24 months: Anne Altmeyer ($31,822.00), Cormorant Asset Management, Lp ($344,132.34), Dominic Smethurst ($26,575.65), Ian Hodgson ($19,537.35), John Kenneth Jenkins ($20,455.05), Sean F Moran ($769,941.43), and Yuval Cohen ($2,452,997.77).

Insiders have sold a total of 133,311 Corbus Pharmaceuticals shares in the last 24 months for a total of $3,665,461.59 sold.

Corbus Pharmaceuticals Active Insiders



This page (NASDAQ:CRBP) was last updated on 5/12/2026 by MarketBeat.com Staff.
From Our Partners